MARKET

NUVB

NUVB

Nuvation Bio Inc
NYSE
4.720
-0.060
-1.26%
After Hours: 4.710 -0.01 -0.21% 19:33 05/14 EDT
OPEN
4.820
PREV CLOSE
4.780
HIGH
4.904
LOW
4.665
VOLUME
3.08M
TURNOVER
--
52 WEEK HIGH
9.75
52 WEEK LOW
1.570
MARKET CAP
1.64B
P/E (TTM)
-11.0255
1D
5D
1M
3M
1Y
5Y
1D
Nuvation Bio Collaborates With Thermo Fisher Scientific For Lung Cancer Treatment
Dow Jones · 1d ago
Nuvation Bio collaborating with Thermo Fisher to manufacture Ibtrozi in NSCLC
TipRanks · 1d ago
Nuvation Bio to Collaborate with Thermo Fisher Scientific for U.S.-Based Manufacturing of IBTROZI® for ROS1-Positive Non-Small Cell Lung Cancer
PR Newswire · 1d ago
Weekly Report: what happened at NUVB last week (0504-0508)?
Weekly Report · 3d ago
A Look At Nuvation Bio (NUVB) Valuation After Profit Shift And Taletrectinib FDA And Guideline Milestones
Simply Wall St · 3d ago
Nuvation Bio Signals Durable Momentum in Earnings Call
TipRanks · 3d ago
Why Nuvation Bio (NUVB) Is Up 8.1% After FDA Accepts IBTROZI Label Update, Strong Q1 Results
Simply Wall St · 4d ago
Results: Nuvation Bio Inc. Confounded Analyst Expectations With A Surprise Profit
Simply Wall St · 6d ago
More
About NUVB
Nuvation Bio Inc. is a global biopharmaceutical company. The Company is engaged in tackling the unmet needs in oncology by developing differentiated and therapeutic candidates. Its programs include taletrectinib (ROS1 inhibitor), safusidenib (mIDH1 inhibitor), NUV-1511 (drug-drug conjugate), and NUV-868 (BET inhibitor). The Company's Taletrectinib is an oral, potent, central nervous system-active, selective, ROS1 inhibitor specifically designed for the treatment of patients with ROS1-positive (ROS1+) non-small cell lung cancer (NSCLC). Safusidenib is a novel, oral, potent, brain penetrant, targeted inhibitor of mutant isocitrate dehydrogenase 1(mIDH1). NUV-1511, a clinical-stage drug-drug conjugate (DDC), fuses a targeting agent to a widely used chemotherapy agent. Its NUV-868 is a BD2-selective, oral, small molecule bromodomain and extra-terminal (BET) inhibitor that inhibits BRD4.

Webull offers Nuvation Bio Inc stock information, including NYSE: NUVB real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NUVB stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading NUVB stock methods without spending real money on the virtual paper trading platform.